Clinigen Group PLC (LON:CLIN) Price Target Increased to GBX 1,200 by Analysts at Peel Hunt
Clinigen Group PLC (LON:CLIN) had its price objective hoisted by analysts at Peel Hunt from GBX 1,015 ($13.15) to GBX 1,200 ($15.54) in a research note issued on Friday. The firm presently has a “buy” rating on the stock. Peel Hunt’s price target would suggest a potential upside of 28.34% from the company’s current price.
CLIN has been the topic of a number of other reports. Stifel Nicolaus restated a “buy” rating and issued a GBX 970 ($12.56) price objective on shares of Clinigen Group PLC in a research note on Tuesday, April 4th. Numis Securities Ltd restated a “buy” rating and issued a GBX 933 ($12.09) price objective on shares of Clinigen Group PLC in a research note on Friday, March 10th. Finally, N+1 Singer restated a “buy” rating and issued a GBX 895 ($11.59) price objective on shares of Clinigen Group PLC in a research note on Wednesday, March 15th.
Shares of Clinigen Group PLC (LON CLIN) opened at 935.00 on Friday. The stock’s market capitalization is GBX 1.07 billion. The stock’s 50 day moving average is GBX 873.16 and its 200 day moving average is GBX 821.26. Clinigen Group PLC has a 1-year low of GBX 590.50 and a 1-year high of GBX 935.00.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/07/08/clinigen-group-plc-lonclin-price-target-increased-to-gbx-1200-by-analysts-at-peel-hunt.html.
In other news, insider John Bacon sold 200,000 shares of the business’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of GBX 843 ($10.92), for a total transaction of £1,686,000 ($2,183,937.82). Also, former CEO Peter George sold 500,000 shares of the business’s stock in a transaction dated Thursday, June 22nd. The stock was sold at an average price of GBX 875 ($11.33), for a total transaction of £4,375,000 ($5,667,098.45).
Clinigen Group PLC Company Profile
Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.